Association between SGLT2 Inhibitors and Cardiac Rehabilitation Outcomes in Patients with Cardiovascular Disease and Type 2 Diabetes Mellitus

The use of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with type 2 diabetes mellitus (T2DM) has been associated with decreased skeletal muscle mass but remains unclear in patients with cardiovascular disease (CVD) undergoing comprehensive outpatient cardiac rehabilitation (CR). The...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashima, Ayuko, Kamiya, Kentaro, Hamazaki, Nobuaki, Ueno, Kensuke, Nozaki, Kohei, Ichikawa, Takafumi, Yamashita, Masashi, Uchida, Shota, Noda, Takumi, Hotta, Kazuki, Maekawa, Emi, Yamaoka-Tojo, Minako, Matsunaga, Atsuhiko, Ako, Junya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571431/
https://www.ncbi.nlm.nih.gov/pubmed/36233823
http://dx.doi.org/10.3390/jcm11195956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571431/
https://www.ncbi.nlm.nih.gov/pubmed/36233823
http://dx.doi.org/10.3390/jcm11195956

Ejemplares similares